 |
|
|
| Internet Search |
|
Stock Search |
|
|
|
|
|
PROVALIS PLC ADR, (PVLS) Stock Rating Learn More
| Our Overall Rating on PROVALIS PLC ADR, PVLS is Not Available | | Provalis plc and its subsidiaries engage in the development and sale of medical diagnostic products and pharmaceuticals in the United States, the United Kingdom, and Ireland. The company primarily operates in two segments, Medical Diagnostics and Pharmaceuticals. The Medical Diagnostics segment develops and sells Glycosal, in2itA1c, and Osteosal medical diagnostic products for diabetes and osteoporosis diagnostic tests. The Pharmaceuticals segment sells and markets its own and third party branded prescription medicines in the United Kingdom and Ireland to GPs and hospitals. It primarily distributes Diclomax, Calceos, Erdotin, Clotam Rapid, and Histofreezer, used in the areas of gastroenterology, osteoporosis, migraine, and dermatology. Provalis was incorporated in February 1997. The company was formerly known as Cortecs (1997) plc and changed its name to Cortecs plc in June 1997. Subsequently, it changed its name to Provalis plc in 1999. The company is based in Deeside, the United Kingdom. | | Our Not Available Rating on PVLS was issued on 11/22/2008 |
PROVALIS PLC ADR Technical Rating
|
|
|
|
